This guideline has been revised and will be updated with further clinical information in due course. In the meantime see the GGC Atrial Fibrillation Management Guideline for information on rate control, anticoagulation and when to refer patients for out-patient specialist assessment. See below for digoxin dosing guidance.
N.B. The direct oral anticoagulant (DOAC) agent of choice is now apixaban - see the apixaban summary of product characteristics for dosing advice, cautions and drug interactions.
Digoxin has a limited role as first-line treatment for rate control. It is usually used second-line in combination with a beta-blocker or calcium-channel blocker.
In frail elderly patients or patients with very low body weight, lower loading and maintenance doses than those advised below may be required. If further advice is required then contact your clinical pharmacist, or Medicines Information (see Appendix 6 for contact details) or out-of-hours the on-call pharmacist.
Loading dose – normal renal function:
Loading dose – renal impairment (creatinine clearance <30ml/minute):
N.B. Digoxin injection: 25micrograms = 0.1ml. Additional loading doses may be required; give according to ventricular (heart rate) response.
Maintenance daily dose: The tables below outline digoxin daily maintenance dosing for patients <60kg (see table 2) and >60kg (see table 3).
CrCl* | Oral | IV |
>50ml/min | 250–312.5micrograms | 175–200micrograms |
20–50ml/min | 125–187.5micrograms | 100micrograms |
<20ml/min | 62.5–125micrograms | 50–75micrograms |
*Creatinine clearance - use the CrCl calculator in the GGC Medicines App, or on SharePoint / Clinical Info (NHS network required) or use the equation here. |
CrCl* | Oral | IV |
>50ml/min | 250–375micrograms | 175–250micrograms |
20–50ml/min | 187.5micrograms | 125micrograms |
<20ml/min | 62.5–125micrograms | 50–75micrograms |
*Creatinine clearance - use the CrCl calculator in the GGC Medicines App, or on SharePoint / Clinical Info (NHS network required) or use the equation here |
Target concentration range: 0.5–2micrograms/L (6–24 hours after the dose)
Time to steady state: 5–10 days
Concentration increased by amiodarone, diltiazem, quinine, verapamil (see BNF for more details).
Guideline reviewed: April 2024
Page updated: April 2024